Form 4: Vita Coco Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Ira Liran, a director of Vita Coco Company, Inc., sold a total of 59,243 shares of common stock for approximately $2.98 million under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Ira Liran, a director of Vita Coco Company, Inc. (COCO), executed sales of common stock on November 24, 2025.
- A total of 25,381 shares were sold directly at a weighted average price of $50.294 per share, with prices ranging from $50.00 to $50.65.
- An additional 33,862 shares were sold indirectly by the Ira Liran 2012 Family Trust at a weighted average price of $50.271 per share, with prices ranging from $50.00 to $50.62.
- The total number of shares sold across both direct and indirect transactions was 59,243.
- The aggregate value of the shares sold is approximately $2,979,100.
- Following these transactions, Ira Liran directly beneficially owns 498,341 shares of common stock.
- The Ira Liran 2012 Family Trust indirectly beneficially owns 602,579 shares of common stock.
- All sales were conducted pursuant to a Rule 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: A director's pre-planned sale of shares under a 10b5-1 plan is a routine transaction, not necessarily indicative of company performance. However, insider selling can sometimes be viewed with slight caution by investors, even if not based on new, non-public information.
Positives
- The shares were sold at a relatively high weighted average price of approximately $50.29 and $50.27 per share, which is favorable for the seller.
Negatives
- A director sold a significant number of shares (59,243 shares), which can sometimes be perceived negatively by the market, even if pre-planned.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This transaction is an individual insider trading report and does not provide broader industry context or trends.
Related Party Transactions
- The indirect sale of 33,862 shares was conducted by the Ira Liran 2012 Family Trust, which is a related party to the reporting person, Ira Liran.
Stakeholder Impact
- Shareholders may note the director's sale of a significant number of shares, which could lead to questions about management's confidence, although the 10b5-1 plan suggests a pre-scheduled divestment rather than a reactive one.
Key Dates
| Date | Description |
|---|---|
| 11/24/2025 | Date of common stock transactions by Ira Liran. |
| 11/25/2025 | Date the Form 4 was signed by Alison Klein, Attorney-in-Fact for Ira Liran. |
Recommendation
holdThe sale of shares by a director under a pre-arranged 10b5-1 plan is a routine event and does not inherently signal a change in the company's fundamental outlook. While insider selling can sometimes be viewed cautiously, this specific transaction is unlikely to warrant a change in investment thesis without additional information.
Keywords
Vita Coco, COCO, Ira Liran, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Director, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.